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Background
CMR techniques are increasingly being used to eval-
uate myocardial extracellular volume (ECV). In the
most commonly applied method, ECV is quantified using
haematocrit-adjusted myocardial and blood T1 values
measured before and after gadolinium bolus. The technique
is based on a two-compartment model, assuming contrast
kinetic effects to be negligible due to a dynamic equilibrium
between blood and myocardium (Dynamic-Equilibrium
CMR; DynEq-CMR). This study aimed to assess the effect
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Table 1 Characteristics of healthy volunteers.
Overall (n=30) Group A (0.10 mmol/Kg) (n=10) Group B (0.15 mmol/Kg) (n=10) Group C (0.20 mmol/Kg) (n=10) p value
Male 15 5 5 5
Age 45±13 (22-65 44±14 (23-65) 45±14 (22-64) 46±13 (28-64) 0.98
Age Male 45±15 (22-65) 44±15 (27-65) 46±17 (22-64) 44±15 (30-60)
Age Female 45±12 (23-64) 45±15 (23-62) 44±12 (28-59) 47±12 (28-64)
Weight (Kg) 73.1±13.8 74.8±12.9 70.3±16.0 73.1±13.8 0.75
Height (m) 1.69±0.10 1.71±0.09 1.67±0.10 1.70±0.11 0.67
BSA (m2) 1.83±0.20 1.87±0.19 1.78±2.4 1.85±0.18 0.65
Systolic BP (mmHg) 114±11 116±11 114±11 112±12 0.63
Diastolic BP (mmHg) 67±11 71±11 65±13 66±7 0.41
eGFR (mL/min/m2) 95±17 94±11 100±20 91±19 0.50
Indexed EDV (mL/m2) 79±8 78±8 79±7 80±8 0.83
Indexed ESV (mL/m2) 26±5 27±5 27±5 26±5 0.78
EF (%) 67±5 66±4 66±4 68±5 0.45
Indexed Mass (g/m2) 45±8 44±9 43±8 47±7 0.46
HR (bpm) 68±9 67±9 70±11 66±8 0.67
Values are mean ± standard deviation. Age range is also given in brackets. BP indicates blood pressure, eGFR estimated glomerular filtration rate, EDV end
diastolic volume; ESV end-systolic volume; EF ejection fraction. ‘Indexed’ refers to indexed to body surface area.
Miller et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):M3
http://www.jcmr-online.com/content/15/S1/M3
© 2013 Miller et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Figure 1 (A) Myocardial (Myo, dashed lines) and blood (continuous lines) T1 relaxation times plotted against time after contrast (Gd-DTPA)
administration. Group A (red) received 0.10mmol/kg contrast, Group B (blue) received 0.15mmol/kg and Group C (green) received 0.20mmol/kg.
Pre-contrast (Time 0) myocardial and blood T1 relaxation times were not significantly different between groups. Post-contrast T1 relaxation times
shortened significantly as contrast dose increased. (B) Myocardial and blood R1 (1/T1) values plotted against time after contrast administration.
Labeling as per A. (C) Dynamic-equilibrium CMR-measured myocardial extracellular volume fraction (ECV) plotted against time following contrast
administration. ECV was significantly higher in group A compared to group B and group C, but there was no significant difference between
groups B and C. ECV increased linearly over time in each group. Error bars represent ±1 SD.
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of contrast dose, post-contrast acquisition time, myocardial
regionality, cardiac cycle and gender on DynEq-CMR ECV
measurement.
Methods
30 healthy volunteers (asymptomatic, no cardiovascular
risk factors, normal examination and ECG; also CMR con-
firmed normal global and regional function with no LGE
in all) were prospectively split into 3 age and sex-matched
groups: group A received 0.10mmol/kg Gd-DTPA, group
B 0.15mmol/kg and group C 0.20mmol/kg (Table 1). Mid-
ventricular short-axis modified look locker inversion
recovery (MOLLI) imaging was performed at 1.5T before,
and at 2min intervals between 2-20mins after, contrast
administration, with same-day hematocrit measurement.
MOLLI imaging was repeated in early systole (150ms after
R wave) pre- and at 10mins post-contrast. Resulting pixel-
wise T1 maps (MatLab) were used to calculate ECV.
(Phantom studies performed prior to patient scanning
determined T1 measurement accuracy and heart-rate cor-
rection algorithm).
Results
Pre-contrast myocardial (A 1051±49ms; B 1045±49ms;
C 1040±43ms; p=0.87) and blood (A 1678±98ms; B 1645
±118ms; C 1686±101ms; p=0.66) T1 times did not differ
significantly between groups. Mean myocardial (A 542
±65ms; B 465±69ms; C 407±55ms; p<0.001) and blood
(A 407±73ms; B 307±67ms; C 252±48ms; p<0.001) T1
averaged over all time points post-contrast shortened sig-
nificantly as contrast dose increased (Figure 1). Mean
ECV was significantly higher in group A compared to
groups B and C (A 27.7±3.7%; B 25.8±3.4%; C 25.8±2.8%;
p<0.001). The difference between groups B and C was
not significant. ECV increased linearly over time in each
group; between 2 and 20mins post-contrast, ECV
increased from 27.2±2.7% to 28.8±3.4%, p=0.020 in
group A; 25.3±2.8% to 26.5±3.2%, p=0.004 in group B;
and 25.2±1.7% to 26.2±2.1%, p=0.068 in group C. ECV
varied significantly between myocardial regions, being
highest in the septum and lowest in the lateral wall in
each group. ECV did not differ significantly between dia-
stole and systole. ECV was significantly higher in females
in each group (A female 29.6±3.0%, male 25.4±3.0%,
p<0.001; B female 27.4±2.7%, male 23.6±2.9%, p<0.001;
C female 26.1±2.8%, male 24.7±2.5%, p=0.027).
Conclusions
The small increase in ECV over time suggests that an
incomplete dynamic equilibrium between blood and myo-
cardium is achieved. DynEq-CMR-derived ECV varies
according to contrast dose, myocardial region and gender.
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